Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Bertin

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Immunity|July 19, 2018
Caspase-8 Collaborates with Caspase-11 to Drive Tissue Damage and Execution of Endotoxic ShockPratyusha Mandal, Yanjun Feng, John D Lyons, et al.
Blood|April 2, 2020
An intestinal organoid-based platform that recreates susceptibility to T-cell-mediated tissue injuryYu Matsuzawa-Ishimoto, Ashley Hine, Yusuke Shono, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with NecroptosisPhilip A Harris, Deepak Bandyopadhyay, Scott B Berger, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase InhibitorsCurt D Haffner, Adam K Charnley, Christopher J Aquino, et al.
Nature Communications|June 8, 2021
Ubiquitylation of MLKL at lysine 219 positively regulates necroptosis-induced tissue injury and pathogen clearanceLaura Ramos Garcia, Tencho Tenev, Richard Newman, et al.
Nature Metabolism|October 9, 2020
Publisher Correction: RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in miceDenuja Karunakaran, Adam W Turner, Anne-Claire Duchez, et al.
American Journal of Ophthalmology|September 10, 2017
Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case SeriesInge L Sarens, Ingele Casteels, Jordi Anton, et al.
Nature Metabolism|September 29, 2020
RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in miceDenuja Karunakaran, Adam W Turner, Anne-Claire Duchez, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic CancerPhilip A Harris, Jill M Marinis, John D Lich, et al.
Redox Biology|February 1, 2022
Inactivation of RIP3 kinase sensitizes to 15LOX/PEBP1-mediated ferroptotic deathAndrew M Lamade, Limin Wu, Haider H Dar, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Immunity|July 19, 2018
Caspase-8 Collaborates with Caspase-11 to Drive Tissue Damage and Execution of Endotoxic ShockPratyusha Mandal, Yanjun Feng, John D Lyons, et al.
Blood|April 2, 2020
An intestinal organoid-based platform that recreates susceptibility to T-cell-mediated tissue injuryYu Matsuzawa-Ishimoto, Ashley Hine, Yusuke Shono, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with NecroptosisPhilip A Harris, Deepak Bandyopadhyay, Scott B Berger, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase InhibitorsCurt D Haffner, Adam K Charnley, Christopher J Aquino, et al.
Nature Communications|June 8, 2021
Ubiquitylation of MLKL at lysine 219 positively regulates necroptosis-induced tissue injury and pathogen clearanceLaura Ramos Garcia, Tencho Tenev, Richard Newman, et al.
Nature Metabolism|October 9, 2020
Publisher Correction: RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in miceDenuja Karunakaran, Adam W Turner, Anne-Claire Duchez, et al.
American Journal of Ophthalmology|September 10, 2017
Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case SeriesInge L Sarens, Ingele Casteels, Jordi Anton, et al.
Nature Metabolism|September 29, 2020
RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in miceDenuja Karunakaran, Adam W Turner, Anne-Claire Duchez, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic CancerPhilip A Harris, Jill M Marinis, John D Lich, et al.
Redox Biology|February 1, 2022
Inactivation of RIP3 kinase sensitizes to 15LOX/PEBP1-mediated ferroptotic deathAndrew M Lamade, Limin Wu, Haider H Dar, et al.
Pageof 12